Company Name

Industry

Location

Revenue

Employees

Global Pharma Tek

Pharmaceuticals

United States, New Jersey

$1B and Over

201-500

Renaissance Lakewood

Pharmaceuticals

United States, New Jersey

$1B and Over

201-500

Zoetis Belgium SA

Pharmaceuticals

United States, New Jersey

$1B and Over

201-500

Intercept Pharmaceuticals

Pharmaceuticals

United States, New Jersey

$250M to $500M

201-500

Keystone Industries

Pharmaceuticals

United States, New Jersey

$250M to $500M

201-500

Eugia US

Pharmaceuticals

United States, New Jersey

$250M to $500M

201-500

Ortho Dermatologics

Pharmaceuticals

United States, New Jersey

$250M to $500M

201-500

Alfasigma USA

Pharmaceuticals

United States, New Jersey

$100M to $250M

201-500

Midas Pharma

Pharmaceuticals

United States, New Jersey

$100M to $250M

201-500

Oyster Point Pharma

Pharmaceuticals

United States, New Jersey

$100M to $250M

201-500

Recordati Rare Diseases North America

Pharmaceuticals

United States, New Jersey

$100M to $250M

201-500

Osmotica Pharmaceutical

Pharmaceuticals

United States, New Jersey

$50M to $100M

201-500

SK Life Science

Pharmaceuticals

United States, New Jersey

$50M to $100M

201-500

Taiho Oncology

Pharmaceuticals

United States, New Jersey

$50M to $100M

201-500

WuXi AppTec, Laboratory Testing Division

Pharmaceuticals

United States, New Jersey

$50M to $100M

201-500

WCG MedAvante-ProPhase

Pharmaceuticals

United States, New Jersey

$50M to $100M

201-500

Cosette Pharmaceuticals

Pharmaceuticals

United States, New Jersey

$50M to $100M

201-500

QPharma

Pharmaceuticals

United States, New Jersey

$25M to $50M

201-500

Quartesian | Now a Part of Veranex

Pharmaceuticals

United States, New Jersey

$25M to $50M

201-500

Avet Pharmaceuticals

Pharmaceuticals

United States, New Jersey

$25M to $50M

201-500